IMR Press / EJGO / Volume 31 / Issue 2 / pii/1630984573490-1555271011

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Original Research
Verification of the accuracy of cervical cytology reports in women referred for colposcopy
Show Less
1 2nd Department of Obstetrics and Gynecology, Hippokratio General Hospital of Thessaloniki, Aristotle University of Thessaloniki
2 Medical School Department of Pharmacology, Aristotle University of Thessaloniki (Greece)
Eur. J. Gynaecol. Oncol. 2010, 31(2), 187–190;
Published: 10 April 2010

Objective: To verify the accuracy of cervical cytology in correlation with colposcopic and histological findings. Design/Setting/Population/ Methods: In this retrospective chart review study 545 women, referred to the outpatient clinic for colposcopy, were included in the study. During the 4-year study period, two consultants performed the colposcopies and further necessary procedures, whereas patient charts were reviewed by two of the co-authors. Results: The median age of the study population was 35 years (range: 16-65). Thirtyfour percent of the cases were new and 11% of the women were referred after receiving their first ever cervical smear. Ninety-two percent (503/545) of the colposcopies were satisfactory. Concordance between colposcopic findings and the histology report was 87%, whereas concordance between cytology and histology reports was as low as 60% for HPV-related lesions, 72% for LGSIL and 86% for HGSIL. “See and Treat” was offered to 53 (10%) women and 48 (90.5%) of them had high-grade lesions on histology justifying treatment at the first visit. Conclusions: The concurrent use of cytology and colposcopy provides better chances for earlier detection of lesions demanding intervention; 80%-90% of patients with severe dyskaryotic smears will have a histology report confirming CIN III. See and treat management can be decided sometimes, if supported by the colposcopic findings, and an audit should confirm accuracy to, at least, 90% of cases.
Cervical screening
Smear test
Back to top